Sciclone Pharma (SCLN) Misses Q1 EPS by 2c; Guides FY11 EPS Above
Tweet Send to a FriendGet Alerts SCLN Hot Sheet
Trade SCLN Now!
Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) reported Q1 EPS of $0.08, $0.02 worse than the analyst estimate of $0.10. Revenue for the quarter came in at $21.7 million versus the consensus estimate of $24.32 million.
Sciclone Pharmaceuticals, Inc. sees FY2011 non-GAAP EPS of $0.52-$0.57, versus the consensus of $0.46.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sciclone Pharmaceuticals, Inc. sees FY2011 non-GAAP EPS of $0.52-$0.57, versus the consensus of $0.46.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- GameStop Corp. (GME) Tops Q1 EPS by 6c; Boosts Lower-End of FY13 EPS Outlook
- Williams-Sonoma, Inc. (WSM) Tops Q1 EPS by 4c; Boosts Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
